1910

Drug discovery is slow and inefficient due to fragmented biological data and limited ability to translate insights into therapeutic candidates.

A multimodal, modality-agnostic AI drug discovery platform that integrates large-scale multimodal data, frontier AI models, and high-throughput lab automation to discover small and large molecule therapeutics.

Biopharma and biotech R&D teams developing new therapeutics.